Diagnosis

148 trials 73 recruiting

Filter these 148 trials by phase, country and sponsor.

Open in Search →

Water absorption in brain of hydrocephalus Recruiting

2024-519933-53-00 Adult hydrocephalus 5 2025-01-29
CXCR4-directed [68Ga]Ga-PentixaFor PET/CT vs AVS performance in a diagnoStic randomized Trial Ultimately comparing hypertenSion outcome in p… Recruiting

2024-512628-12-00 Primary aldosteronism 10 2025-01-28
PET/CT imaging with FAPI as a biomarker for the distinction between predominant active fibrotic and inflammatory phenotypes in patients with… Recruiting

2023-503686-26-02 Progressive Pulmonary Fibrosis (PPF) 9 2025-01-24
A first-in-human study to determine the safety and tolerability of different doses of GEH200520 Injection and GEH200521 (18F) Injection and … Recruiting

2024-515218-42-00 Irresectable or metastatic solid tumour or a local and 1 2025-01-23
A Phase 2 diagnostic study with 68Ga-EVG321 in Patients with Small Cell Lung Cancer Recruiting

2024-514584-25-00 Small Cell Lung Cancer 4 2024-12-16
Inventarisation of the value of FAPI and FDG-PET-CT in the diagnosis of acute phase Peyronie’s Disease Recruiting

2024-518838-82-00 Peyronie's Disease 6 2024-12-13
The detection of tumor-associated fibrosis in colorectal peritoneal metastases by FAPI-PET (TROMPET) Recruiting

2024-512301-16-01 Metastatic colorectal cancer 3 2024-12-12
[68Ga]-FAPI PET/CT to visualize the activity of fibrogenic cells in patients with non-resolving shock lung. Recruiting

2024-517257-27-00 Non-resolving ARDS 11 2024-11-24
mFBG PET-CT for neuroblastoma Recruiting

2022-501694-39-01 (suspision on) Neuroblastoma 9 2024-11-12
A pilot study of the safety and tolerability of oral administration of PD L 506 and the subsequent diagnostic value of porphyrin concentrati… Recruiting

2023-508668-31-00 Colorectal Carcinoma 4 2024-11-12
MYELOFLUDATEP: Exploratory study evaluating the value of 18F-Fludarabine PET for the initial or relapsed assessment and therapeutic evaluati… Recruiting

2024-515219-23-00 multiple myeloma 3 2024-11-08
Subtyping Primary Aldosteronism with Para-chloro-2-[18F]fluoroethyl-etomidate ([18F]CETO) Recruiting

2023-508254-26-00 Primary aldosteronism 7 2024-11-06
18F-DPA714 PET-MRI study to improve preoperative localisation of the epileptic focus to be resected in drug-resistant partial epilepsy. Recruiting

2024-517638-16-00 Patients with drug-resistant epilepsy who are candidate 3 2024-11-04
68Ga-FAPI-46 PET/CT for predicting histological response in triple-negative breast cancer Recruiting

2023-507860-37-00 Breast cancer 9 2024-10-14
HYPER-trial Hyperemic mYocardial Perfusion by adEnosine at diffeRent doses Recruiting

2023-505248-20-00 Chronic coronary syndrome 6 2024-10-14
[68Ga]Ga-PentixaFor positron emission tomography for improved risk and disease assessment in myeloma Recruiting

2022-501811-14-00 Multiple Myeloma 9 2024-09-20
HYSTINDO_Study of the vascularization of the vaginal slice after total laparoscopic hysterectomy, using indocyanine green injection. Prospec… Recruiting

2024-511467-28-00 total hysterectomy 6 2024-09-20
Clinical use of USPIO contrast media in the assessment of pelvic lymph node metastasis in rectal cancer. Recruiting

2024-514831-34-00 Rectal cancer 5 2024-09-19
A clinical trial to be conducted in many hospitals and in different countries with the medicinal substance Regadenoson to be used in a type … Recruiting

2024-515244-22-00 Patients who need to undergo a clinically indicated pha 9 2024-09-09
In vivo quantification of Hsp90 in the human brain in healthy aging and neurodegeneration using the novel PET radioligand [11C]HSP990 Recruiting

2023-510532-36-00 Alzheimer's Disease 1 2024-09-04
Evaluating the Diagnostic Performance of Human Epidermal Growth Factor Receptor 2 (HER2) targeted Positron Emission Tomography and Computed … Recruiting

2024-511419-22-00 Hormone receptor positive/HER2 negative, triple-negativ 10 2024-09-03
Improving diagnostics in cervical dysplasia Recruiting

2024-517151-12-00 Patients are either or both HPV positive and has cervic 6 2024-09-01
First-in-human (FIH), microdosing, non-randomized, clinical trial to investigate binding of positron emission tomography tracer [68Ga]Ga-DOT… Recruiting

2023-506555-15-00 Metabolic dysfunction-associated steatotic liver diseas 1 2024-08-19
Molecular imaging with FAPI for diagnosing the CSM4 colorectal cancer subtype Recruiting

2023-509183-17-00 Colorectal cancer, liver metastases 3 2024-08-01